Fig. 3.
Effect of the prescription dose of the HDR brachytherapy boost treatment (single fraction) to EBRT on target
, TCP,
, and UTCP. Values are obtained by plan selection under scenario (i) for each prescription dose over the whole cohort of patients. The red dashed lines illustrate the median UTCP according to the current prescription used at CHUQ-UL (15 Gy). The green dashed-dotted lines illustrate the prescription (10 Gy) that maximizes the median UTCP for the whole cohort of patients.
